BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31059035)

  • 1. Identification of a long noncoding RNA signature to predict outcomes of glioblastoma.
    Li D; Lu J; Li H; Qi S; Yu L
    Mol Med Rep; 2019 Jun; 19(6):5406-5416. PubMed ID: 31059035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long non-coding RNA signature in glioblastoma multiforme predicts survival.
    Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK
    Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
    Gong Z; Hong F; Wang H; Zhang X; Chen J
    BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
    Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
    J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A robust two-gene signature for glioblastoma survival prediction.
    Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
    J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
    Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p.
    Jiang G; Dong H; Dong Y; Yang X
    Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Six-LncRNA Expression Signature Associated with Prognosis of Colorectal Cancer Patients.
    Zhao J; Xu J; Shang AQ; Zhang R
    Cell Physiol Biochem; 2018; 50(5):1882-1890. PubMed ID: 30396175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Series of Nine Long Noncoding RNAs Associated with Survival of Patients with Glioblastoma.
    Lei B; Yu L; Jung TA; Deng Y; Xiang W; Liu Y; Qi S
    J Neurol Surg A Cent Eur Neurosurg; 2018 Nov; 79(6):471-478. PubMed ID: 29959764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
    Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.
    Sun J; Cheng L; Shi H; Zhang Z; Zhao H; Wang Z; Zhou M
    Sci Rep; 2016 Jun; 6():27842. PubMed ID: 27292966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M; Long S; Hu J; Wang Z; Geng C; Ou S
    Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the Outcome for Patients with Glioblastoma with lncRNA Expression Profiles.
    Liu Q; Qi C; Li G; Su W
    Biomed Res Int; 2019; 2019():5076467. PubMed ID: 31950039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
    Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
    Zhou M; Zhang Z; Zhao H; Bao S; Cheng L; Sun J
    Mol Neurobiol; 2018 May; 55(5):3684-3697. PubMed ID: 28527107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.